Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas

OBJECTIVE: We estimate the effect size of hypoglycemia risk reduction on closed-loop control (CLC) versus open-loop (OL) sensor-augmented insulin pump therapy in supervised outpatient setting. RESEARCH DESIGN AND METHODS: Twenty patients with type 1 diabetes initiated the study at the Universities o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovatchev, Boris P., Renard, Eric, Cobelli, Claudio, Zisser, Howard C., Keith-Hynes, Patrick, Anderson, Stacey M., Brown, Sue A., Chernavvsky, Daniel R., Breton, Marc D., Mize, Lloyd B., Farret, Anne, Place, Jérôme, Bruttomesso, Daniela, Del Favero, Simone, Boscari, Federico, Galasso, Silvia, Avogaro, Angelo, Magni, Lalo, Di Palma, Federico, Toffanin, Chiara, Messori, Mirko, Dassau, Eyal, Doyle, Francis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Diabetes Care Symposium
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067397/
https://www.ncbi.nlm.nih.gov/pubmed/24929429
http://dx.doi.org/10.2337/dc13-2076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067397/
https://www.ncbi.nlm.nih.gov/pubmed/24929429
http://dx.doi.org/10.2337/dc13-2076

Ejemplares similares